HOME › DRUGS › OMBITASVIR, PARITAPREVIR, RITONAVIR
ACTIVE SUBSTANCE / INN

OMBITASVIR, PARITAPREVIR, RITONAVIR

Brand name(s): VIEKIRA PAK (COPACKAGED)
FDA LISTED
DISCONTINUED
NDA206619
ACTIVE SUBSTANCE
Ombitasvir, Paritaprevir, Ritonavir
REGULATORS
FDA
SPONSORS / MAH
ABBVIE
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VIEKIRA PAK (COPACKAGED)NDA206619ABBVIEDiscontinued

FULL INTELLIGENCE ON OMBITASVIR, PARITAPREVIR, RITONAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →